Table 3 Associations of signs and symptoms with visceral leishmaniasis relapse and death
Variables | Follow-up adverse outcomes | |||
|---|---|---|---|---|
VL relapse | Death | |||
OR (95% CI) | p value | OR (95% CI) | p value | |
Disease history data | ||||
Fever | 1.35 (.72–2.53) | .335 | 1.10 (.41–3.04) | .832 |
Hair loss | .80 (.28–2.16) | .667 | – | .133 |
Diarrhea | 1.06 (.57–1.98) | .828 | .83 (.30–2.20) | .707 |
Vomiting | .97 (.46–2.03) | .954 | .87 (.23–2.70) | 1.000 |
Bleeding | 1.27 (.55–2.91) | .555 | .56 (.12–2.57) | .743 |
Cough | 1.16 (.59–2.27) | .658 | .83 (.25–2.39) | .740 |
Dyspnea | .87 (.44–1.71) | .702 | 1.80 (.65–4.84) | .229 |
Increased abdominal volume | 1.00 (.51–1.94) | .987 | 1.31 (.45–3.56) | .584 |
Physical evaluation | ||||
Emaciation | .93 (.49–1.75) | .832 | 3.83 (1.15–17.11) | .043 |
Febrile | 1.03 (.49–2.16) | .922 | 1.69 (.55–4.77) | .313 |
Jaundice | .75 (.31–1.73) | .502 | 1.96 (.58–5.87) | .225 |
Alopecia | .44 (.09–1.65) | .362 | – | .364 |
Spotting | 1.75 (.49–6.49) | .528 | 1.83 (.25–8.52) | .356 |
Bleeding | 1.26 (.41–3.76) | .665 | 2.14 (.44–8.05) | .381 |
Edema | .75 (.24–2.13) | .588 | 4.05 (1.13–13.17) | .012 |
Dyspnea | .61 (.18–1.84) | .385 | .50 (.02–3.09) | 1.000 |
Abdominal protrusion | 1.16 (.57–2.34) | .669 | .76 (.20–2.33) | .784 |
Hepatomegaly | .81 (.41–1.61) | .557 | 1.60 (.52–5.89) | .592 |
Splenomegaly | 2.20 (1.13–4.37) | .018 | 1.66 (.58–5.39) | .346 |
Adenomegaly | 3.11 (1.02–10.52) | .037 | .54 (.02–3.36) | 1.000 |